{"id":"https://openalex.org/W7168165366","doi":"https://doi.org/10.1016/j.compbiolchem.2026.109235","title":"A tissue-aware computational framework for confounding-controlled co-expression network analysis: Context-dependent utility in drug sensitivity modelling","display_name":"A tissue-aware computational framework for confounding-controlled co-expression network analysis: Context-dependent utility in drug sensitivity modelling","publication_year":2026,"publication_date":"2026-07-13","ids":{"openalex":"https://openalex.org/W7168165366","doi":"https://doi.org/10.1016/j.compbiolchem.2026.109235","pmid":"https://pubmed.ncbi.nlm.nih.gov/42442052"},"language":"en","primary_location":{"id":"doi:10.1016/j.compbiolchem.2026.109235","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.compbiolchem.2026.109235","pdf_url":null,"source":{"id":"https://openalex.org/S104924063","display_name":"Computational Biology and Chemistry","issn_l":"1476-9271","issn":["1476-9271","1476-928X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Computational Biology and Chemistry","raw_type":"journal-article"},"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.compbiolchem.2026.109235","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5121773431","display_name":"Marc R\u00edos-Cadenas","orcid":null},"institutions":[{"id":"https://openalex.org/I95013407","display_name":"Universidad Pablo de Olavide","ror":"https://ror.org/02z749649","country_code":"ES","type":"education","lineage":["https://openalex.org/I95013407"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marc R\u00edos-Cadenas","raw_affiliation_strings":["SynergIA Laboratory (SIALAB), Universidad Pablo de Olavide, Ctra. Utrera km. 1, Seville, ES-41013, Spain"],"raw_orcid":"https://orcid.org/0009-0002-8400-0114","affiliations":[{"raw_affiliation_string":"SynergIA Laboratory (SIALAB), Universidad Pablo de Olavide, Ctra. Utrera km. 1, Seville, ES-41013, Spain","institution_ids":["https://openalex.org/I95013407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121803200","display_name":"Iv\u00e1n Segura-Carmona","orcid":null},"institutions":[{"id":"https://openalex.org/I95013407","display_name":"Universidad Pablo de Olavide","ror":"https://ror.org/02z749649","country_code":"ES","type":"education","lineage":["https://openalex.org/I95013407"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Iv\u00e1n Segura-Carmona","raw_affiliation_strings":["SynergIA Laboratory (SIALAB), Universidad Pablo de Olavide, Ctra. Utrera km. 1, Seville, ES-41013, Spain"],"raw_orcid":"https://orcid.org/0009-0002-9620-7809","affiliations":[{"raw_affiliation_string":"SynergIA Laboratory (SIALAB), Universidad Pablo de Olavide, Ctra. Utrera km. 1, Seville, ES-41013, Spain","institution_ids":["https://openalex.org/I95013407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077542496","display_name":"Aurelio L\u00f3pez L\u00f3pez","orcid":"https://orcid.org/0000-0001-5986-5437"},"institutions":[{"id":"https://openalex.org/I95013407","display_name":"Universidad Pablo de Olavide","ror":"https://ror.org/02z749649","country_code":"ES","type":"education","lineage":["https://openalex.org/I95013407"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Aurelio L\u00f3pez-Fern\u00e1ndez","raw_affiliation_strings":["SynergIA Laboratory (SIALAB), Universidad Pablo de Olavide, Ctra. Utrera km. 1, Seville, ES-41013, Spain"],"raw_orcid":"https://orcid.org/0000-0001-5986-5437","affiliations":[{"raw_affiliation_string":"SynergIA Laboratory (SIALAB), Universidad Pablo de Olavide, Ctra. Utrera km. 1, Seville, ES-41013, Spain","institution_ids":["https://openalex.org/I95013407"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5140535113","display_name":"Francisco A. G\u00f3mez-Vela","orcid":null},"institutions":[{"id":"https://openalex.org/I95013407","display_name":"Universidad Pablo de Olavide","ror":"https://ror.org/02z749649","country_code":"ES","type":"education","lineage":["https://openalex.org/I95013407"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Francisco A. G\u00f3mez-Vela","raw_affiliation_strings":["SynergIA Laboratory (SIALAB), Universidad Pablo de Olavide, Ctra. Utrera km. 1, Seville, ES-41013, Spain. Electronic address: fgomez@upo.es"],"raw_orcid":"https://orcid.org/0000-0001-7376-5790","affiliations":[{"raw_affiliation_string":"SynergIA Laboratory (SIALAB), Universidad Pablo de Olavide, Ctra. Utrera km. 1, Seville, ES-41013, Spain. Electronic address: fgomez@upo.es","institution_ids":["https://openalex.org/I95013407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5140535113"],"corresponding_institution_ids":["https://openalex.org/I95013407"],"apc_list":{"value":2960,"currency":"USD","value_usd":2960},"apc_paid":{"value":2960,"currency":"USD","value_usd":2960},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.75324933,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"124","issue":"Pt 2","first_page":"109235","last_page":"109235"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10887","display_name":"Bioinformatics and Genomic Networks","score":0.7307000160217285,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10887","display_name":"Bioinformatics and Genomic Networks","score":0.7307000160217285,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10621","display_name":"Gene Regulatory Network Analysis","score":0.11079999804496765,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.019099999219179153,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sensitivity","display_name":"Sensitivity (control systems)","score":0.6628000140190125},{"id":"https://openalex.org/keywords/key","display_name":"Key (lock)","score":0.34929999709129333},{"id":"https://openalex.org/keywords/computational-model","display_name":"Computational model","score":0.29589998722076416},{"id":"https://openalex.org/keywords/artificial-neural-network","display_name":"Artificial neural network","score":0.27219998836517334}],"concepts":[{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.7081999778747559},{"id":"https://openalex.org/C21200559","wikidata":"https://www.wikidata.org/wiki/Q7451068","display_name":"Sensitivity (control systems)","level":2,"score":0.6628000140190125},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.43369999527931213},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.3962000012397766},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.38280001282691956},{"id":"https://openalex.org/C26517878","wikidata":"https://www.wikidata.org/wiki/Q228039","display_name":"Key (lock)","level":2,"score":0.34929999709129333},{"id":"https://openalex.org/C66024118","wikidata":"https://www.wikidata.org/wiki/Q1122506","display_name":"Computational model","level":2,"score":0.29589998722076416},{"id":"https://openalex.org/C50644808","wikidata":"https://www.wikidata.org/wiki/Q192776","display_name":"Artificial neural network","level":2,"score":0.27219998836517334},{"id":"https://openalex.org/C11413529","wikidata":"https://www.wikidata.org/wiki/Q8366","display_name":"Algorithm","level":1,"score":0.24230000376701355},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.23600000143051147}],"mesh":[{"descriptor_ui":"D000077547","descriptor_name":"Crizotinib","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053263","descriptor_name":"Gene Regulatory Networks","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.compbiolchem.2026.109235","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.compbiolchem.2026.109235","pdf_url":null,"source":{"id":"https://openalex.org/S104924063","display_name":"Computational Biology and Chemistry","issn_l":"1476-9271","issn":["1476-9271","1476-928X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Computational Biology and Chemistry","raw_type":"journal-article"},{"id":"pmid:42442052","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42442052","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Computational biology and chemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.compbiolchem.2026.109235","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.compbiolchem.2026.109235","pdf_url":null,"source":{"id":"https://openalex.org/S104924063","display_name":"Computational Biology and Chemistry","issn_l":"1476-9271","issn":["1476-9271","1476-928X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Computational Biology and Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323583","display_name":"Fundaci\u00f3n General CSIC","ror":"https://ror.org/03byqb733"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1966327575","https://openalex.org/W1980497534","https://openalex.org/W2011474181","https://openalex.org/W2050249255","https://openalex.org/W2095956310","https://openalex.org/W2096863518","https://openalex.org/W2106391833","https://openalex.org/W2108068107","https://openalex.org/W2108933868","https://openalex.org/W2461427403","https://openalex.org/W2770828094","https://openalex.org/W2893209354","https://openalex.org/W2944727022","https://openalex.org/W2955502047","https://openalex.org/W2982602983","https://openalex.org/W3000285141","https://openalex.org/W3094540299","https://openalex.org/W3130522707","https://openalex.org/W3130891725","https://openalex.org/W4364378476","https://openalex.org/W4393159318","https://openalex.org/W4394014190","https://openalex.org/W4395696738","https://openalex.org/W4396605932","https://openalex.org/W4402128677","https://openalex.org/W4410715874"],"related_works":[],"abstract_inverted_index":{"Pan-cancer":[0],"pharmacogenomic":[1],"modelling":[2],"using":[3],"co-expression":[4,156,216],"networks":[5],"faces":[6],"a":[7,31,53,104,210],"fundamental":[8],"challenge:":[9],"topological":[10,94],"metrics":[11],"predominantly":[12],"encode":[13],"tissue":[14,49,90],"identity":[15,91],"rather":[16],"than":[17],"genuine":[18,113],"pharmacological":[19],"signal,":[20],"inflating":[21],"apparent":[22],"predictive":[23,153],"performance":[24],"and":[25,43,78,142,198],"undermining":[26],"biological":[27],"interpretability.":[28],"We":[29],"introduce":[30],"tissue-aware":[32],"computational":[33,212],"framework":[34,61],"integrating":[35],"tissue-specific":[36],"WGCNA":[37,101],"construction,":[38],"within-tissue":[39],"edge":[40],"disruption":[41],"profiling,":[42],"per-gene":[44],"z":[45],"-score":[46],"standardisation,":[47],"with":[48,84,222],"prediction":[50],"accuracy":[51],"as":[52],"quantitative":[54],"acceptance":[55],"criterion":[56,125],"for":[57,214],"confounder":[58],"control.":[59],"The":[60],"was":[62],"applied":[63],"to":[64,98,225],"660":[65],"cancer":[66],"cell":[67],"lines":[68],"across":[69,108],"three":[70,110],"targeted":[71],"therapies":[72],"(osimertinib,":[73],"crizotinib,":[74],"KRAS":[75,143],"G12C":[76,144],"Inhibitor-12)":[77],"evaluated":[79,205],"under":[80],"repeated":[81],"stratified":[82],"cross-validation":[83],"FDR":[85],"correction.":[86],"Within-tissue":[87,100],"standardisation":[88],"reduced":[89],"encoding":[92],"in":[93,165,181,219],"features":[95,174],"from":[96,179],"88.9%":[97],"12.9%.":[99],"modules":[102],"outperformed":[103],"confounder-free":[105],"PCA":[106],"baseline":[107,172],"all":[109],"drugs,":[111],"confirming":[112],"co-regulatory":[114],"structure":[115],"beyond":[116],"dimensionality":[117],"reduction.":[118],"Osimertinib":[119],"met":[120],"the":[121,152,182,190,199],"pre-specified":[122],"primary":[123],"improvement":[124],"(":[126],"\u0394":[127],"\u03c1":[128],"=":[129,186],"+":[130],"0.063":[131],",":[132],"p":[133],"adj":[134],"<":[135],"0.001":[136],"versus":[137],"tissue-residualised":[138],"expression),":[139],"while":[140],"crizotinib":[141],"Inhibitor-12":[145],"showed":[146,170],"no":[147],"meaningful":[148],"improvement,":[149],"establishing":[150],"that":[151,171],"benefit":[154],"of":[155],"topology":[157],"is":[158],"highly":[159],"drug-context-dependent.":[160],"A":[161],"proof-of-concept":[162],"feasibility":[163],"check":[164],"an":[166],"independent":[167],"cohort":[168],"(GSE255958)":[169],"expression":[173],"discriminated":[175],"drug-tolerant":[176],"persister":[177],"cells":[178],"responders":[180],"EGFR":[183],"context":[184],"(AUC":[185],"0.758":[187],"),":[188],"though":[189],"small":[191],"sample":[192],"size":[193],"precludes":[194],"strong":[195],"inferential":[196],"claims":[197],"network":[200,217],"component":[201],"could":[202],"not":[203],"be":[204],"externally.":[206],"This":[207],"work":[208],"establishes":[209],"reproducible":[211],"standard":[213],"confounder-controlled":[215],"analysis":[218],"pan-cancer":[220],"pharmacogenomics,":[221],"direct":[223],"applicability":[224],"any":[226],"CCLE-":[227],"or":[228],"GDSC-scale":[229],"study.":[230]},"counts_by_year":[],"updated_date":"2026-08-02T14:50:37.381335","created_date":"2026-07-14T00:00:00"}